Executive Summary

About 10 million U.S. patients face catastrophic out-of-pocket risk for specialty and orphan drugs (roughly a $200B market at an average $20K annual drug spend), and many of those patients fall into coverage gaps or high-deductible plans where access requires weeks of manual paperwork and coordination. Patient assistance programs (PAPs), charity grants, short-term financing and prior-authorizations are available but fragmented and labor-intensive, causing treatment delays, nonadherence, and downstream costs for providers and payers. You could build an AI-driven patient assistance and navigation platform that combines OCR intake, machine-learning eligibility matching, a PAP rules engine and automated document assembly with human-in-the-loop case management and EHR/pharmacy integrations. The product would aim to cut time-to-access from weeks to hours, route the right financial solution (foundation grant, copay coupon, bridge loan) in real time, and provide measurable ROI signals to clinics and payers. This market is attractive now because specialty drug prices continue to rise and insurance churn/high-deductible enrollment are increasing the number of patients who need quick, short-term solutions; at the same time, AI/OCR maturity makes automation of previously manual enrollment feasible and economically defensible. To stand out you would need proprietary rule logic, deep operational partnerships with pharma foundations and pharmacies, and strong integrations that demonstrate cost avoidance and adherence improvements; honest challenges include regulatory and privacy compliance, the fragmented and changing rules across funds and payers, and the sales cycle required to earn trust from health systems and manufacturers.

Market Opportunity

Catastrophic med-cost risk — AI-driven patient assistance & navigation targets a $200B = 10M high-cost Rx patients x $20K average annual spend (U.S. specialty and orphan drugs market) total addressable market with medium saturation and a year-over-year growth rate of 8-12% -- specialty drug spend and out-of-pocket exposure are growing faster than overall healthcare spend.

Key trends driving demand: Rising specialty drug prices -- increases number of patients at risk of catastrophic out-of-pocket costs, driving demand for assistance.; Insurance churn and high-deductible plans -- more people temporarily uninsured/underinsured who need quick price solutions and short-term financing.; AI/OCR maturity -- automates labor-intensive PAP enrollment and document collection, cutting time-to-access from weeks to hours.; Expansion of telepharmacy & e-prescribing APIs -- enables instant routing to discount networks and alternative fulfillment channels..

Key competitors include GoodRx, SingleCare, NeedyMeds (and RxAssist), Manufacturer Patient Assistance Programs (PAPs) & Specialty Pharmacies, GoFundMe (crowdfunding / workaround).

Sign in to access

Catastrophic med-cost risk — AI-driven patient assistance & navigation

Executive Summary

Market Validation

Market Opportunity

More in HealthTech

Replace manual pharmacy ops with AI-driven billing, inventory & CRM

Helping people manage stress & anxiety with a personalized AI companion

Cumbersome food logging -> passive AI meal capture with portion inference

HIPAA BAA blockers — AI contract review + pre-approved vendor marketplace

Reduce missed clinic appointments by automating patient outreach via WhatsApp

Too many leads not converting — automate patient conversion flow